Review





Similar Products

nmda receptor antagonist d ap5  (MedChemExpress)
95
MedChemExpress nmda receptor antagonist d ap5
Nmda Receptor Antagonist D Ap5, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/pm41423560-372-27-33?v=MedChemExpress
Average 95 stars, based on 1 article reviews
nmda receptor antagonist d ap5 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
nmda receptor antagonist d ap5  (Hello Bio Inc)
86
Hello Bio Inc nmda receptor antagonist d ap5
Nmda Receptor Antagonist D Ap5, supplied by Hello Bio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/pm41803111-273-6-37?v=Hello+Bio+Inc
Average 86 stars, based on 1 article reviews
nmda receptor antagonist d ap5 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
selective nmda receptor antagonist  (Tocris)
96
Tocris selective nmda receptor antagonist
(A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in <t>the</t> <t>AMPA/NMDA</t> ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.
Selective Nmda Receptor Antagonist, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/bio_rxiv__64898__2026__02__13__705680-55-27-31?v=Tocris
Average 96 stars, based on 1 article reviews
selective nmda receptor antagonist - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
non competitive nmda receptor antagonist mk801  (Tocris)
96
Tocris non competitive nmda receptor antagonist mk801
(A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in <t>the</t> <t>AMPA/NMDA</t> ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.
Non Competitive Nmda Receptor Antagonist Mk801, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/pmc12867824-71-7-14?v=Tocris
Average 96 stars, based on 1 article reviews
non competitive nmda receptor antagonist mk801 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
cpp nmda receptor antagonist tocris cat no 0247  (Tocris)
95
Tocris cpp nmda receptor antagonist tocris cat no 0247
(A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in <t>the</t> <t>AMPA/NMDA</t> ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.
Cpp Nmda Receptor Antagonist Tocris Cat No 0247, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/bio_rxiv__64898__2026__01__14__699178-172-35-39?v=Tocris
Average 95 stars, based on 1 article reviews
cpp nmda receptor antagonist tocris cat no 0247 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
nmda glutamate receptor antagonist  (Tocris)
96
Tocris nmda glutamate receptor antagonist
(A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in <t>the</t> <t>AMPA/NMDA</t> ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.
Nmda Glutamate Receptor Antagonist, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/us12515077-449-12-37?v=Tocris
Average 96 stars, based on 1 article reviews
nmda glutamate receptor antagonist - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
nmda glutamate receptor antagonist rs  (Tocris)
94
Tocris nmda glutamate receptor antagonist rs
(A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in <t>the</t> <t>AMPA/NMDA</t> ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.
Nmda Glutamate Receptor Antagonist Rs, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/pm41436475-261-11-20?v=Tocris
Average 94 stars, based on 1 article reviews
nmda glutamate receptor antagonist rs - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
nmda receptor antagonist d apv  (Tocris)
96
Tocris nmda receptor antagonist d apv
(A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in <t>the</t> <t>AMPA/NMDA</t> ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.
Nmda Receptor Antagonist D Apv, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+antagonists/pm41389410-276-14-20?v=Tocris
Average 96 stars, based on 1 article reviews
nmda receptor antagonist d apv - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

Image Search Results


(A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in the AMPA/NMDA ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.

Journal: bioRxiv

Article Title: Compound- and sex-specific medial prefrontal cortex rewiring after prenatal THC and CBD exposure

doi: 10.64898/2026.02.13.705680

Figure Lengend Snippet: (A, B) Averaged fEPSP amplitudes plotted as a function of stimulus intensity. Synaptic strength remains stable across treatments, indicating that baseline recruitment does not account for the observed plasticity differences. (C) CBD-exposed males show a significant increase in the AMPA/NMDA ratio in layer V pyramidal neurons of the mPFC. (D) Representative traces of NMDA-EPSCs (red) evoked at +30 mV in the presence of 50 µM NBQX, and AMPA-EPSCs (blue) obtained by digital subtraction of the NMDA component from the dual-component current at +30 mV. (E, F) CBD alters the kinetics of evoked NMDA currents. Male CBD-exposed offspring exhibit slower rise times, whereas CBD-exposed females display faster decay kinetics. (A, B) Each point represents the group mean at the corresponding stimulus intensity; data are shown as mean ± SEM in XY plots and analyzed using a multiple-measures Mann–Whitney test. (C, E, F) Each point represents a single neuron; data are presented as violin plots (median and 25th–75th percentiles) and analyzed using two-way ANOVA followed by Šídák’s multiple-comparison test. Only statistically significant differences (p < 0.05) are indicated.

Article Snippet: GABA-sIPSCs were recorded at − 70 mV in presence of 20 μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).

Techniques: MANN-WHITNEY, Comparison